Introduction
Acute coronary syndrome is an emergency situation requiring immediate diagnosis and treatment. Unstable angina, Non ST elevation myocardial infarction, and ST elevation myocardial infarction collectively constitute the diagnosis of acute coronary syndrome 1 . Cardiovascular disease (CVD) are the leading cause of death worldwide. World Health Organization (WHO) predicted that coronary heart disease will be the top of the contributors to disease burden by 2020 and world will face an impending epidemic of the disease. The prevalence of coronary heart disease was estimated as 3.3/1000 in 1976 and 17.2/1000 in 1986 indicating 5 folds increase disease in 10 years. The incidence is similar in other developed countries and is rising at an alarming rate in developing part of the world. The management of patients with acute coronary syndrome is one of the major challenges presently in the field of Cardiology 1,2 . High admission blood glucose levels after myocardial infarction are common and are associated with an increased risk of death in subjects with and without diabetes. In this review, the possible toxic action of acute hyperglycemia is discussed in order to explain the worse prognosis in subjects with myocardial - infarction; and concomitant hyperglycemia 3 . In recent years, much attention has been given to the evidence that the concomitant occurrence of hyperglycemia in patients admitted to intensive care units (ICU) with an acute myocardial infarction enhances risk of mortality and morbidity, whether the patients has diabetes or not 4 . However, a positive association between hyperglycemia at the time of the event and subsequent mortality from has frequently been reported 5 . This may mean that besides being causal, elevated glucose also could be a marker of existing insulin resistance and / or beta cell failure that may contribute to the poor prognosis through other mechanisms.
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Materials And Methods
This is an observational cross-sectional study was carried out in Coronary Care Unit (CCU), Rajshahi Medical College Hospital (RMCH) and laboratorical tests were carried out in Diabetic Hospital at Rajshahi. Sample size was 248. Patients admitted to coronary care unit in RMCH with ACS and with no known history of diabetes were recruited for the study. Criteria for the diagnosis of acute myocardial infarction such as: a) Typical history of chest pain, b) ECG change and c) Cardiac enzymes elevation. Any two of the above three criteria is considered as acute myocardial infarction. Patients with thyroid diseases, renal failure, heart failure, severely debilated conditions and previous known history of diabetes were excluded. FBS and standard OGTT within 3 days were done after clinically and hemo dynamically stable from acute illness of ACS patients. Usually on the 2nd or 3rd day, fasting blood sample was drawn for estimation of plasma glucose and HbA1c. All of the remaining subjects underwent glucose tolerance test with 75gm glucose load on the 3rd day after admission. Blood sample collection was done under aseptic precaution with the consent of patients. All samples were sent to laboratory. The Characteristics of total study group and the sub groups in relation to the glucose tolerance status reveals that age, BMI and blood pressure parameters were not significantly different among the sub-groups. Plasma glucose values were significantly higher in the newly diagnosed diabetic subjects On the other hand, mean age was 51.88±12.89 where had high blood glucose level. (Table-3) . 
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Conclusions
Diabetes is common among patients with acute coronary syndromes. Morbidity and mortality after such event is high. This study deals with risk factors for increased mortality; how to improve care and prognosis in patients with diabetes mellitus and acute coronary syndrome. ACS is a medical emergency requiring immediate diagnosis and treatment. It is increasing at an alarming rate in developing part of the world. The management of patients of ACS is one of the major challenges. Acute hyperglycemia is a new risk factor during acute MI. It enhances the risk of mortality and morbidity. Acute MI related complications are also more. The prevalence of diabetes, previously not known diabetes and glucose disturbances preceding diabetes is much higher than previously considered among patients with acute coronary syndrome. Patients with acute hyperglycemia are possible to detect already during the initial hospitalization for a coronary event. An abnormal test results after an OGTT implies increased risk for both future DM and diabetes specific complication and for future cardiovascular morbidity and mortality 13, 14 .
